What the buyer needs

AI summary

The Department of Veterans Affairs seeks information from qualified sources to manufacture and deliver sterile, USP 825 compliant, low enriched uranium radiopharmaceuticals to the VA San Diego Healthcare System Nuclear Medicine Service. The required scope includes routine next-business-day delivery, 24/7 emergency delivery within one hour, dose labels compatible with the Nuclear Medicine Information System database, and support for research radiopharmaceuticals across a base year and four option years running from January 1, 2027, through December 31, 2031. Eligible vendors must align with NAICS code 325412, have fewer than 1,300 employees to be considered small, and provide an authorization letter if not the original equipment manufacturer. Interested parties must email capability statements, pricing, and business size details to [email protected] by November 6, 2026, at 10:00 AM Mountain Time.

Scope of work

Manufacturing and delivery of sterile/aseptic, USP 825 compliant, low enriched uranium (LEU) radiopharmaceuticals
Provision of DOT-compliant shipment and delivery for radioactive drugs
Stat delivery services within 1 hour available 24 hours per day, 365 days per year
Provision of dose labels compatible with the Nuclear Medicine information System computerized database
Storage, preparation, labeling and delivery of research radiopharmaceuticals as requested
Next business day delivery for routine orders
Supply of specific radiopharmaceuticals including I-123, I-131, In-111, 99mTc, Tl-201, Ga-67, and GA-68 formulations
Packaging, marking, and transfer of radioactive materials under local, state, and federal regulations

Minimum qualifications

Delivery personnel trained in Radiation Safety Techniques, NRC, Joint Commission safety guidelines, and DOT requirements
Ability to comply with USP 825 and DOT requirements for shipment of radioactive drugs
Original Equipment Manufacturer (OEM), authorized dealer, authorized distributor, or authorized reseller
Vendor personnel must have picture ID and be able to speak English

Documents to include with your response

Capabilities statement illustrating how organization can or cannot meet SOW requirements
Responses to questions 1 through 15 listed in the notice
SAM.gov Unique Entity ID and CAGE Code number
Signed OEM authorization letter on manufacturer letterhead (unless vendor is the OEM)
General pricing information (encouraged for market research)

How to submit

Method: email
Instructions: Submit via email to [email protected]; telephone responses will not be accepted.

Incumbent and award research

Likely prior awards for this requirement

Likely match

Awarded by the same buying office (36C262) with descriptions matching "radiopharmaceuticals". The notice does not name its current contract, so confirm before relying on it.

Vendor and award	Value	Ends
CARDINAL HEALTH 414, LLC36C26224P0890 · RADIOPHARMACEUTICALS BASE PLUS FOUR OPTION YEARS	$1.4M	Feb 28, 2029

Market context

Awards in the same category (Pharmaceutical Preparation Manufacturing). This is not this requirement's award history.

Recent similar awards: Department of Veterans Affairs, NAICS 325412

Vendor and award	Value	Ends
PHARMALOGIC LTD36C24126P0126 · RADIOPHARMACEUTICALS	$135.8K	Dec 31, 2030
CARDINAL HEALTH 414, LLC36C24126P0009 · RADIOPHARMACEUTICALS	$70,000	Nov 25, 2030
EXELAN PHARMACEUTICALS INC36C24226N0564 · LENALIDOMIDE	$3.1M	May 31, 2029
RLS (USA) INC.36C26224P0297 · RADIOPHARMACEUTICALS	$1.1M	Nov 30, 2028

Top vendors in this category: Department of Veterans Affairs, NAICS 325412, since Oct 1, 2024

4,161 contract awards in this NAICS over the period.

1. MCKESSON CORPORATION$26.1B
2. EXELAN PHARMACEUTICALS INC$100.2M
3. PROGENICS PHARMACEUTICALS INC$84.9M
4. CARDINAL HEALTH 414, LLC$61.2M
5. NOVARTIS PHARMACEUTICALS CORPORATION$55.3M

Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.